华仁药业：公司将持续积极跟进债务化解进度

Group 1 - The core viewpoint of the article is that Huaren Pharmaceutical (300110) is committed to actively following up on debt resolution progress to maximize the recovery of losses and protect the legal rights of the company and all shareholders [1] Group 2 - The company is responding to investor inquiries on its interactive platform, indicating transparency and engagement with stakeholders [1] - The focus on maximizing loss recovery suggests a proactive approach to financial management and risk mitigation [1] - The commitment to maintaining shareholder rights highlights the company's dedication to its investors and overall corporate governance [1]